Your browser doesn't support javascript.
loading
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.
Marsavela, Gabriela; Lee, Jenny; Calapre, Leslie; Wong, Stephen Q; Pereira, Michelle R; McEvoy, Ashleigh C; Reid, Anna L; Robinson, Cleo; Warburton, Lydia; Abed, Afaf; Khattak, Muhammad A; Meniawy, Tarek M; Dawson, Sarah-Jane; Sandhu, Shahneen; Carlino, Matteo S; Menzies, Alexander M; Scolyer, Richard A; Long, Georgina V; Amanuel, Benhur; Millward, Michael; Ziman, Melanie R; Rizos, Helen; Gray, Elin S.
Afiliación
  • Marsavela G; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Lee J; Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Calapre L; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Wong SQ; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
  • Pereira MR; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • McEvoy AC; Peter MacCallum Cancer Centre, Victoria, Australia.
  • Reid AL; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.
  • Robinson C; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Warburton L; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Abed A; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Khattak MA; Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Australia.
  • Meniawy TM; School of Biomedical Science, University of Western Australia, Crawley, Australia.
  • Dawson SJ; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Sandhu S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Carlino MS; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Menzies AM; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Scolyer RA; Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Australia.
  • Long GV; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Amanuel B; Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Australia.
  • Millward M; School of Medicine, University of Western Australia, Crawley, Australia.
  • Ziman MR; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
  • Rizos H; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Gray ES; School of Medicine, University of Western Australia, Crawley, Australia.
Clin Cancer Res ; 26(22): 5926-5933, 2020 11 15.
Article en En | MEDLINE | ID: mdl-33067256

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / ADN Tumoral Circulante / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / ADN Tumoral Circulante / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Australia